Point72 Asia Singapore Pte. Ltd. Sells 7,466 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Point72 Asia Singapore Pte. Ltd. decreased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 71.0% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 3,052 shares of the company’s stock after selling 7,466 shares during the period. Point72 Asia Singapore Pte. Ltd.’s holdings in Privia Health Group were worth $53,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Benjamin F. Edwards & Company Inc. raised its position in shares of Privia Health Group by 8.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock valued at $134,000 after acquiring an additional 605 shares during the last quarter. Arizona State Retirement System raised its position in shares of Privia Health Group by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock valued at $462,000 after acquiring an additional 617 shares during the last quarter. Signaturefd LLC raised its position in shares of Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after acquiring an additional 626 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of Privia Health Group by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock valued at $176,000 after acquiring an additional 756 shares during the last quarter. Finally, Parkside Financial Bank & Trust raised its position in shares of Privia Health Group by 9.7% during the 2nd quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company’s stock valued at $151,000 after acquiring an additional 771 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the transaction, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 14.20% of the company’s stock.

Privia Health Group Trading Up 1.4 %

Shares of NASDAQ PRVA opened at $17.59 on Friday. The firm has a market cap of $2.10 billion, a PE ratio of 117.27, a PEG ratio of 4.22 and a beta of 0.76. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $24.35. The company has a fifty day moving average price of $19.23 and a 200 day moving average price of $18.45.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The business had revenue of $422.30 million for the quarter, compared to analyst estimates of $411.50 million. During the same quarter in the prior year, the company earned $0.06 earnings per share. The company’s quarterly revenue was up 2.2% on a year-over-year basis. Equities research analysts forecast that Privia Health Group, Inc. will post 0.16 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on PRVA. Royal Bank of Canada reissued an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Evercore ISI decreased their price target on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Finally, Robert W. Baird boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. Two analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Privia Health Group has a consensus rating of “Moderate Buy” and an average target price of $24.86.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.